Paragate Medical, an NGT3 VC portfolio company, has developed a remote, implantable solution for heart and kidney failure patients.
Most remote solutions use telematics to offer some type of remote monitoring. Founders Dr. Yair Feld, Nitai Hanani, and the team at Paragate have developed a solution that monitors and provides 24/7 home-based care to patients coping with chronic heart and kidney failure.
Paragate’s IPUD (Implantable Peritoneal Ultrafiltration Device) is a minimally invasive and fully implantable device that serves as a mechanical bypass of the kidneys. It actively, continuously, and non-aggressively removes excess fluid from the body to keep patients balanced at home.
The company conducted successful preclinical studies and is planning to begin the clinical trials this year. Paragate Medical is part of Nazareth-based NGT3, a venture capital firm investing in life science start-ups led by Arab and Jewish entrepreneurs with a strong belief that the most effective platform for strengthening Jewish-Arab relations is an economic one, allowing for collaboration and the opportunity to build meaningful relationships.
